Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
Clinical trial NCT05739292 · COMPLETED
Trial details
- NCT number
- NCT05739292
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2023-05-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.